Evidence map›Paper›PMID 40304354›Full record

ArticleChinese medical journal2025

Clinical outcomes of standard vs . delayed initiation of immediate-release tacrolimus following donation after circulatory death in kidney transplantation in China: Results from a randomized controlled trial.

Lan Zhu, Zhangfei Shou, Jinliang Xie, Jianghua Chen, Changxi Wang, Wenli Song, Min Gu, Jing Wu, Martin Blogg, Mohamed Soliman and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chinese medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Lan ZhuTongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430040, China.
Zhangfei ShouShulan (Hangzhou) Hospital, Hangzhou, Zhejiang 310000, China.
Jinliang XieXiangya Hospital of Central South University, Changsha, Hunan 410008, China.
Jianghua ChenThe First Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang 310003, China.
Changxi WangThe First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, China.
Wenli SongTianjin First Central Hospital, Tianjin 300192, China.
Min GuJiangsu Province Hospital, Nanjing, Jiangsu 210029, China.
Jing WuAstellas China Investment Co., Ltd, Beijing, 100022, China.
Martin BloggAstellas Pharma Europe, Addlestone, KT15 2NX, UK.
Mohamed SolimanAstellas Pharma Singapore Pte Ltd., 038986, Singapore.
Ruijin HeAstellas China Investment Co., Ltd, Beijing, 100022, China.
Wujun XueThe First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China.
Zhishui ChenTongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430040, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40304354
PMCPMC12091582

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.